University of Southern California: Carcinoma trials

The registry lists 20 Carcinoma studies with University of Southern California as lead sponsor. 0 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 6Phase 2 7No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical CarcinomaCompletedNCT00184093Phase 1/2Results posted
• Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00184028Phase 2Results posted
• A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)TerminatedNCT00183963Phase 2Results posted
• Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal CarcinomaCompletedNCT00183794Phase 2Results posted
• 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
• Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal CancerWithdrawnNCT03576963Phase 1/2
• Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerWithdrawnNCT03563352
• sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder CancerWithdrawnNCT03552796Phase 1
• Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 RadioembolizationWithdrawnNCT03300401Not applicable
• Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder TumorsWithdrawnNCT03238664Not applicable
• Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon CancerTerminatedNCT03137706
• Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung CancerCompletedNCT03091816
• sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney CancerTerminatedNCT02767921Phase 1
• MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver CancerCompletedNCT02578602Phase 1
• Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder CancerTerminatedNCT02494635
• Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast CancerCompletedNCT02370277
• Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial CancerWithdrawnNCT01943058Phase 2
• Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerWithdrawnNCT01639521Phase 2
• Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast CancerCompletedNCT01219075Not applicable
• Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1